A Unique Option for Pain and Irritable Bowel Option Your Healthcare Provider May Not Know About

A Unique Option for Pain and Irritable Bowel Option Your Healthcare Provider May Not Know About

A Unique Option for Pain and Irritable Bowel Option Your Healthcare Provider May Not Know About

A 2018 Dartmouth-Hitchcock Medical Center study1 concluded that “based on current reports of numerous benefits and an excellent safety profile, clinical use of Low Dose Naltrexone or ‘LDN’ may be seen as a reasonable option in patients with fibromyalgia or irritable bowel disease.”

This 18 page paper also serves as an excellent resource for exploring this low cost treatment option. This review discusses the properties of naltrexone, mechanism of action of low dosing and summaries of clinical trials of LDN for Multiple Sclerosis, Complex Regional Pain Syndrome, Fibromyalgia, GI disorders, dermatological conditions and cancer.

Fibromyalgia Results

  • 32.5% symptom reduction for LDN versus 2.3% on placebo
  • 57% of patients responded 
  • Patients’ satisfaction with life and mood was significantly better while taking LDN 
  • LDN had same side effects as placebo

Irritable Bowel Disease Results

  • Majority responded with a 70-point decrease in Crohn’s disease activity index (89%) and achieved remission (67%)
  • Drug was safe and tolerable and LDN provided clinical benefits
  • Clinical improvement in majority (74.5%) of patients who previously had intractable disease, while some (25.5%) achieved remission
  • LDN use was associated with significant reduction in consumption of anti-inflammatory medications

LDN is a low cost option with few side effects which studies are showing to be effective in treating pain, irritable bowel disease, mental health and autoimmune conditions. Your health care provider doesn’t know about it because it’s almost 60 years old so no drug companies are promoting it.

It’s also not available from your regular pharmacy. You see, the naltrexone dose used is so low that it must be specially compounded. The commercial product is a 50mg tablet but for “Low Dose Naltrexone”, the dose ranges from 1mg to 9mg. 

Our accredited Nebraska compounding pharmacy regularly compounds low dose naltrexone in a variety of strengths for many autoimmune and pain conditions. In addition to serving Nebraskans with their compounded medications, we are also a licensed compounding pharmacy in Kansas, Colorado, Iowa and South Dakota.

To learn more about LDN, visit our Low Dose Naltrexone page or call the pharmacy (402-462-2929)!